ArticleACS omega2025
Copper(II) Complexes Derived from Halogen-Substituted Schiff Base Ligands: Synthesis, Crystal Structures, Antibacterial Activity, and Molecular Docking Studies.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mono- and dinuclear thiophene-based palladium(ii) complexes bearing phosphorus ylides: synthesis, catalytic activity, cytotoxicity and molecular docking studies.RSC advances · 2026Article
- DNA/BSA binding, antidiabetic and antioxidant studies of copper(ii) complexes derived fromRSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the face of escalating bacterial resistance to conventional antibiotics, the quest for novel antimicrobial strategies is urgenter than ever. Metal complexes, particularly those with biological activity, stand out as a promising alternative due to their unique mechanisms of action and potential for fewer side effects in comparison to standard organic antibiotics. This investigation focuses on the synthesis and characterization of six Cu-(II) complexes, each formulated from halogen-substituted bidentate Schiff base ligands. Employing a suite of analytical methods, Fourier transform infrared, UV-vis, elemental analysis, and single-crystal X-ray diffraction, the structures of the complexes were fully established. All of the complexes were assigned to have square planar geometry, with the ligand acting as a bidentate and coordinate to the Cu-(II) ion via nitrogen and oxygen atoms. The antibacterial efficacy of these complexes was rigorously tested against both Gram-positive bacteria
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.